GGiantBullStocks

Royalty Pharma plc - Class A Ordinary Shares (RPRX)

NASDAQ · Healthcare

$57.29-1.52%

As of Jul 20, 2026

Price history

Key statistics

Market cap
$24.48B
P/E ratio
EPS
Volume
3,245,519
52-week high
52-week low
Open
$58.34
Day high
$58.95
Day low
$57.22

Financial highlights

Fiscal yearRevenueNet incomeEPS
2025$2.38B$770.95M$1.78
2024$2.26B$858.98M$1.91
2023$2.35B$1.13B$2.53
2022$2.24B$42.83M$0.10
2021$2.29B$619.73M$1.49

About Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

CEO
Pablo Legorreta
Employees
100
Country
US
IPO date
Jun 16, 2020

Similar stocks

Other Healthcare companies

Frequently asked questions

What is Royalty Pharma plc - Class A Ordinary Shares's stock price today?
RPRX is trading at $57.29 as of Jul 20, 2026.
What is Royalty Pharma plc - Class A Ordinary Shares's market cap?
Royalty Pharma plc - Class A Ordinary Shares (RPRX) has a market capitalization of $24.48B.
Does Royalty Pharma plc - Class A Ordinary Shares pay a dividend?
Yes. In FY2025, Royalty Pharma plc - Class A Ordinary Shares paid $0.22 per share in dividends.
What sector is Royalty Pharma plc - Class A Ordinary Shares in?
Royalty Pharma plc - Class A Ordinary Shares operates in the Healthcare sector.